The NUTRIATE study represents collaboration between CERU and an industry sponsor to investigate a novel molecule to enhance gastric emptying in critically ill patients. Subjects will be recruited in Canada, the US and Australia.
Status of the study: Recruiting
Providing optimal delivery of enteral nutrition (EN) early in the clinical course of critically-ill patients is recognized as an integral component of high quality standard supportive care. Gastric emptying is impeded in 40-60% of ICU patients. This results in an inability to deliver adequate enteral nutrition to our patients, an increase in gastric residual volumes (GRVs), and a potential aspiration of gastric contents. Will repeat doses of GSK962040 enhance gastric emptying and, thereby, increase the delivery of enteral nutrition to mechanically-ventilated critically-ill patients that have conditions which predispose them to delayed gastric emptying.
This trial is registered at ClinicalTrials.gov (NCT01934192).